Lactulosa Therapy and Gastrointestinal Side Effects

Mechanism and Adverse Effects

The American Gastroenterological Association recommends starting with a lower dose of lactulosa and increasing it as tolerated to minimize gastrointestinal side effects 1
Lactulosa is a synthetic disaccharide that acts as an osmotic laxative in the colon, promoting peristalsis, and can cause gastrointestinal side effects such as nausea, vomiting, gas distension with flatulence or belching, and abdominal discomfort like cramps in approximately 20% of patients 1

The initial recommended dose of lactulosa for treating hepatic encephalopathy is 25 ml of lactulosa syrup every 1-2 hours until at least 2 soft stools are produced per day, with subsequent dosage adjustment to maintain 2-3 stools per day 2, 3
The American Gastroenterological Association recommends a dose of 10-20 g of lactulosa daily for treating constipation, which can be increased to 40 g daily if necessary, to minimize gastrointestinal side effects 1

In patients with hepatic encephalopathy, the lack of effect of lactulosa should prompt a clinical search for unrecognized precipitating factors and competitive causes for cerebral deterioration 2, 3

Patients on lactulosa therapy should be monitored for abdominal distension and flatulence, common side effects, and consideration should be given to reducing the dose or using alternative laxatives if abdominal pain is significant 1
It is a misconception that the lack of effect of smaller amounts of lactulosa can be remedied with much larger doses, which can lead to complications 2, 3

Lactulose provides dual benefits in patients with any history of liver dysfunction: it treats constipation while simultaneously preventing hepatic encephalopathy (HE) by reducing ammonia absorption through its osmotic laxative effect and intestinal acidification 4, 5
Constipation is a known precipitating factor for hepatic encephalopathy in patients with liver disease, and guidelines specifically recommend "enema or laxatives" for constipation management in this population 4, 5
Simple laxatives like senna lack the prebiotic properties of disaccharides and do not have the ammonia-reducing effects that lactulose provides 6, 7
The American Association for the Study of Liver Diseases and European Association for the Study of the Liver explicitly note that "simple laxatives alone do not have the prebiotic properties of disaccharides, and no publications have been forthcoming on this issue" 7

Lactulose is safe and well-tolerated in patients with current or prior liver dysfunction 4, 5
Avoid excessive dosing of lactulose, as this can lead to dehydration, hypernatremia, and severe diarrhea 8
If constipation persists despite adequate lactulose dosing, investigate for other causes rather than simply increasing the dose further 8

For patients with Grade 3 or 4 hepatic encephalopathy, lactulose enema may be used when oral intake is contraindicated or impossible, with a preparation of 300 mL lactulose mixed with 700 mL water or normal saline, as recommended by the American Association for the Study of Liver Diseases, with a strength of evidence based on clinical guidelines 9, 10
The goal of lactulose therapy is to achieve 2-3 soft bowel movements per day, with a maximum dose of 60 mL (40 g) daily for constipation, according to the Clinical and Molecular Hepatology guidelines 10

Titrate lactulose dose every few days to achieve the desired bowel movement frequency, with careful monitoring of serum potassium and sodium levels, especially in elderly patients on diuretics, to avoid hypokalemia and hypernatremia, as recommended by the Clinical and Molecular Hepatology guidelines 10
Avoid excessive dosing that leads to more than 3 soft stools daily, as this can cause dehydration and electrolyte disturbances, with a goal of 2-3 soft stools per day, according to the Clinical and Molecular Hepatology guidelines 10